H. Lundbeck Investor Relations Material
Latest events
Q4 2024
H. Lundbeck
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from H. Lundbeck
Access all reports
Segment Data
Access more data
Revenue by
Product
Brintellix®/Trintellix®
Rexulti®/Rxulti®
Other pharmaceuticals
Abilify Maintena®
Other
Expenses by
Financials
H. Lundbeck A/S develops, manufactures, and sells pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, the United States, Canada, and internationally. The company offers psychiatric products, including Abilify Maintena for maintenance treatment of adults with bipolar I disorder or schizophrenia; Risperdal Consta for maintenance treatment of schizophrenia; Vraylar/Lenvima/Xalkori for treating schizophrenia in various countries; Brintellix/Trintellix for treating major depressive disorder; and Rexulti/Brexiprazole as adjunctive therapy with antidepressants in treating adult patients with major depressive disorder. The company was founded in 1915 and is headquartered in Valby, Denmark.
Key slides for H. Lundbeck
Q1 2024
H. Lundbeck
CMD 2024
H. Lundbeck
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
LUN
Country
🇩🇰 Denmark